The recommended baseline panel for menopausal women considering weight loss peptides includes: fasting glucose and HbA1c (metabolic baseline), fasting insulin (insulin resistance assessment), lipid panel including triglycerides (cardiovascular risk), complete metabolic panel (liver and kidney function), IGF-1 (baseline for GH secretagogue monitoring), thyroid panel including TSH and free T4, estradiol and FSH (menopausal status confirmation), and DEXA scan if available (body composition baseline)
only the compounding and distribution model differ, enabling lower costs
The medication's effect on gastric emptying is most pronounced after the initial doses and tends to diminish over time with continued treatment
Minimizes wrinkles Collagen and elastin production naturally dwindle as you get older
Federal law permits pharmacies to compound medications in limited circumstances, such as when a patient requires a customized formulation
Figure 5B)